Zola P. Horovitz is Director at BIOCRYST PHARMACEUTICALS INC (BCRX). They have made 4 open-market trades across 3 companies since 2006, most recently 2015-12-08.
CIK 0001033507
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $18K since 2008, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PTN | BUY | 2012-12-24 | 2012-12-27 | $0.60 | $6K | +214.8% | +52.3% | +52.3% |
| GNVC | BUY | 2011-08-12 | 2011-08-16 | $2.37 | $7K | -68.2% | -1.1% | -1.1% |
| BCRX | SELL · 10b5-1 | 2010-03-15 | 2010-03-16 | $7.22 | $72K | -26.4% | -2.7% | -2.7% |
| BCRX | SELL · 10b5-1 | 2010-02-01 | 2010-02-03 | $6.85 | $69K | -26.4% | -2.7% | -2.7% |
| AVGN | SELL | 2009-11-19 | 2009-11-20 | $1.43 | $7K | N/A | N/A | N/A |
| GNVC | BUY | 2008-11-21 | 2008-11-21 | $0.50 | $5K | -68.2% | -1.1% | -1.1% |
| DOVP | SELL · 10b5-1 | 2006-03-13 | 2006-03-15 | $17.43 | $216K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.